Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Astellas Pharma Inc
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Jazz Pharmaceuticals
University of Utah
University of Florida
Takeda
Beth Israel Deaconess Medical Center
Duke University
University of Pennsylvania
Novartis